查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198056

气道正压通气市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Positive Airway Pressure Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

所研究的气道正压通气 (PAP) 市场预计在预测期内的复合年增长率约为 4.6%。

COVID-19 大流行使持续气道正压通气成为人们关注的焦点。 由于对气道正压通气 (PAP) 的需求增加，患有睡眠呼吸暂停的患者在 COVID-19 封锁期间对 PAP 的依从性显着增加。 发表在 European Respiratory Journal 2020 上的一篇论文发现，在封锁的第一个月（2020 年 3 月 15 日至 2020 年 4 月 15 日），4.48% 的 PAP 依从性得到确认。

市场增长的主要驱动因素是久坐不动的生活方式、缺乏身体活动以及肥胖人数增加导致的饮食失调，这些已被确定为睡眠障碍的最常见致病因素。全球睡眠流行率综合症等疾病正在上升。 例如，根据世界卫生组织2021年报告，2020年将有超过20亿18岁以上的成年人超重。 其中，超过 6.5 亿人肥胖，导致睡眠呼吸暂停增加。

预计在预测期内，全球睡眠呼吸暂停患病率的增加将提振市场。 根据 Adam V. Benjafield 发表在 Lancet Respiratory Medicine 2020 上的论文，全球有 9.36 亿 30-69 岁的成年人患有轻度至重度阻塞性睡眠呼吸暂停 (OSA)，而 30-69 岁的成年人中估计有 4.25 亿患有中度到严重的 OSA。 同样，50-60% 的肥胖人群和代谢综合征 (MS) 患者被认为患有 OSA。 因此，预计睡眠呼吸暂停综合征患病率上升将推动气道正压通气市场的增长。

此外，在整个预测期内，人们对睡眠呼吸暂停、心血管疾病和高血压等风险因素的认识不断提高，预计也将提振 PAP 市场。

气道正压市场趋势

持续气道正压装置有望在气道正压市场占据最大市场份额

CPAP（持续气道正压通气）是一种气道正压通气，它持续向人的上呼吸道施加大于大气压的恆定压力。 持续气道正压通气 (CPAP) 设备占据了最大的市场份额，因为它们被用作治疗各种睡眠障碍的一线 PAP 疗法。

根据《柳叶刀呼吸医学》2020 年发表的论文“是时候唤醒阻塞性睡眠呼吸暂停的巨人了”，仅在英国，每年约有 800 万 30-69 岁的人患上阻塞性睡眠呼吸暂停综合征 (OSA)。)据说受影响。 对 CPAP 机器的巨大需求在多种情况下帮助了许多睡眠呼吸暂停患者，例如通过控制气压和在机器内的泵的帮助下打开阻塞的气道等气道阻塞，因为它已被证明。

产品发布和批准、合作伙伴关係、协作和併购等许多市场发展将推动气道正压通气市场的发展。 2019 年 3 月，总部位于美国的医疗器械公司瑞思迈宣布将收购 HB Healthcare (HBH)，收购金额不详。 通过这笔交易，ResMed 将在 HB Healthcare 和值得信赖的分销商合作伙伴网络的支持下，接触到韩国人民，帮助韩国数百万患有睡眠呼吸暂停、慢性阻塞性肺病和其他呼吸系统疾病的人。希望提供 CPAP和人们的呼吸护理。

患者更喜欢 CPAP 机器，因为它具有多种好处，例如增加能量水平、改善情绪、提高精神警觉性和改善睡眠质量，从而导致这些系统的采用率增加并刺激市场增长。是吗？

北美主导市场，预计在预测期内也会如此

在整个预测期内，预计北美将主导全球 PAP 市场。 这种主导地位是由于美国糖尿病、高血压、肥胖、阻塞性睡眠呼吸暂停 (OSA) 和呼吸困难等肺部疾病患病率上升等因素导致对 PAP 设备的需求量增加。 例如，2020 年美国国家医学研究所发布的一份报告估计，美国 OSA 的患病率男性高达 14%，女性高达 5%。 西班牙裔、黑人和亚裔人口比例较高，推动了预测期内的市场增长。

根据疾病控制和预防中心的行为风险因素监测系统 (BFRSS) 2019，美国成人肥胖率为 42.4%。 这是全国平均水平首次超过40%。 肥胖症的增加正在推动对睡眠呼吸暂停的需求，推动气道正压通气市场。

随着可支配收入的增加、人口老龄化、空气污染的迅速增加以及该地区的技术进步，负担能力的提高也是预测期内全球市场收入中突出的因素。这有助于增加市场分享。

气道正压通气市场竞争分析

持续气道正压通气市场竞争适中，由几家大型企业组成。 从市场收入的角度来看，目前主导市场的一些知名企业正在积极收购，而其他企业则推出新产品。 例如，2019 年 3 月，瑞思迈收购了 HB Healthcare (HBH)，以加强其在韩国 CPAP 和呼吸护理市场的领先地位，提供睡眠呼吸暂停、慢性阻塞性肺疾病 (COPD) 和其他呼吸系统疾病。 目前主导市场的公司包括 Koninklijke Philips NV、ResMed Inc.、Smiths Group PLC、3B Medical Inc. 和 Apex Medical Corp。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 由于人口老龄化和可支配收入增加，全球医疗保健支出增加
    • 全球睡眠障碍患病率上升
    • 技术进步
  • 市场製约因素
    • 在患有大疱性肺病和严重流鼻血等疾病的患者中使用这些设备的相关并发症
    • 气道正压通气设备成本高
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • CPAP（持续气道正压通气）设备
    • 自动气道正压通气 (APAP) 装置
    • 双层气道正压 (BiPAP) 装置
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Koninklijke Philips NV
    • Apex Medical Corp.
    • Compumedics Limited
    • 3B Medical Inc.
    • Medical Depot Inc.
    • ResMed Inc.
    • Smiths Group PLC
    • Fisher & Paykel Healthcare Limited
    • Lowenstein Medical UK Ltd
    • Vyaire Medical Inc.
    • Drive DeVilbiss Healthcare LLC
    • Rotech Healthcare Inc.

第7章 市场机会今后动向

简介目录
Product Code: 68172

The positive airway pressure (PAP) market studied was anticipated to witness a CAGR of nearly 4.6% during the forecast period.

The COVID-19 pandemic turned the spotlight on continuous positive airway pressure. Since sleep apnea patients have an increasing demand for positive airway pressure (PAP), adherence to PAP significantly increased during the COVID-19 lockdown. According to the article published in the European Respiratory Journal 2020, a 4.48% increase in PAP adherence was observed during the first month of lockdown (15 March 2020 to 15 April 2020) compared to the same time in 2019.

The major factors attributing to the growth of the market are a rise in the global prevalence of sleep disorders such as sleep apnea due to the rise in the sedentary lifestyle, physical inactivity, and poor dietary habits resulting in increased obesity population, which was identified as the most common causative factor of sleep disorders. For instance, according to the World Health Organization report 2021, in 2020, more than 2 billion adults, 18 years and older, were overweight. Of these, over 650 million were obese, leading to a rise in sleep apnea.

The increasing global prevalence of sleep apnea is expected to boost the market over the forecast period. According to the article published in Lancet Respiratory Medicine 2020 by Adam V. Benjafield, globally, 936 million adults aged 30-69 had mild to severe obstructive sleep apnoea (OSA), and 425 million adults aged 30-69 had moderate to severe OSA. Similarly, it is believed that 50-60% of the obese population and patients with metabolic syndrome (MS) suffer from OSA. Thus, the growing prevalence of sleep apnea is expected to drive positive airway pressure market growth.

Also, increased awareness of sleep apnea and risk factors such as cardiovascular indications and high blood pressure are expected to fuel the PAP market throughout the forecast period.

Positive Airway Pressure Market Trends

Continuous Positive Airway Pressure Devices Expected to Hold the Largest Market Share in the Positive Airway Pressure Market

Continuous positive airway pressure (CPAP) is a type of positive airway pressure ventilation in which a steady pressure larger than atmospheric pressure is continuously applied to a person's upper respiratory tract. Continuous positive airway pressure (CPAP) devices contribute to the largest share in the market because they are used as a first-line PAP therapy to treat various sleep disorders.

According to the article published in The Lancet Respiratory Medicine 2020, "Time to wake the giant of obstructive sleep apnoea", around 8 million people aged 30-69 years are affected by obstructive sleep apnoea (OSA) in the United Kingdom alone each year. The massive demand for the CPAP devices is due to their proven efficiency in many sleep apnea patients in multiple cases, such as airway blockages, by controlling the air pressure with the help of a pump in the device to open up the blocked airways.

Many developments are taking place, including product launches and approvals, partnerships, collaborations, and mergers and acquisitions that can boost the positive airway pressure market. In March 2019, Resmed, a medical equipment firm based in the United States, announced the acquisition of HB Healthcare (HBH) for an undisclosed sum. With this agreement, Resmed hopes to reach out to Korean people with the support of HB Healthcare and its network of trusted distributor partners to provide CPAP and respiratory care to millions of South Koreans suffering from sleep apnea, COPD, and other respiratory disorders.

The patients' increased preference for CPAP devices due to various advantages such as increased energy levels, improved mood, mental alertness, and quality of sleep increase their demand, contributing to the rise in adoption of these systems and fueling the market growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the global PAP market throughout the forecast period. The dominance is due to factors such as the rising prevalence of diabetes, high blood pressure, obesity, obstructive sleep apnea (OSA), and pulmonary disorders, such as dyspnea in the United States, which is to higher demand for the PAP devices. For instance, according to reports published by the National Institute of Medicine in 2020, in the United States, OSA prevalence was estimated to be as high as 14% of men and 5% of women. Hispanic, black, and Asian populations have higher rates, which drives the market growth in the forecast period.

According to the Centers for Disease Control and Prevention's Behavioral Risk Factors Surveillance System (BFRSS) 2019, the adult obesity percentage in the United States was 42.4%. This was the first time the national average surpassed 40%. The growing prevalence of obesity increases the demand for sleep apnea, thereby driving the market for positive airway pressure market.

Also, increased affordability with a rise in disposable income, an aging population, a surge in high levels of air pollution, and technological advancements in the region contribute to its outstanding share in the global market revenue during the forecast period.

Positive Airway Pressure Market Competitor Analysis

The continuous positive airway pressure therapy market is moderately competitive and consists of several major players. In terms of market revenue, a few prominent players currently dominating the market are vigorously making acquisitions while others are launching new products. For example, in March 2019, ResMed consolidated its leading role in Korea's CPAP and respiratory care market by acquiring HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Some companies currently dominating the market include Koninklijke Philips NV, ResMed Inc., Smiths Group PLC, 3B Medical Inc., and Apex Medical Corp.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Defination
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population and Rise in Global Healthcare Expenditure, along with Growth in Disposable Income
    • 4.2.2 Rise in Global Prevalence of Sleep Disorders
    • 4.2.3 Advancement in Technologies
  • 4.3 Market Restraints
    • 4.3.1 Complications Associated with the Use of these Devices in Patients with Diseases, like Bullous Lung Disease and Severe Nosebleeds
    • 4.3.2 High Cost of Positive Airway Pressure Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Continuous Positive Airway Pressure (CPAP) Devices
    • 5.1.2 Automatic Positive Airway Pressure (APAP) Devices
    • 5.1.3 Bilevel Positive Airway Pressure (BiPAP) Devices
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Koninklijke Philips NV
    • 6.1.2 Apex Medical Corp.
    • 6.1.3 Compumedics Limited
    • 6.1.4 3B Medical Inc.
    • 6.1.5 Medical Depot Inc.
    • 6.1.6 ResMed Inc.
    • 6.1.7 Smiths Group PLC
    • 6.1.8 Fisher & Paykel Healthcare Limited
    • 6.1.9 Lowenstein Medical UK Ltd
    • 6.1.10 Vyaire Medical Inc.
    • 6.1.11 Drive DeVilbiss Healthcare LLC
    • 6.1.12 Rotech Healthcare Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS